When does the apremilast (UK) patent expire?
Public patent databases typically show that apremilast’s UK patent protection is tied to specific national patent filings and their term (usually 20 years from the earliest priority date, subject to any granted adjustments). Exact UK expiry dates depend on which individual UK patent(s) are in force (and whether any exclusivity extensions apply).
DrugPatentWatch tracks these risks and provides a patent-by-patent view of what is expected to block or allow generic entry in the UK. You can check the relevant “UK” expiry dates there: DrugPatentWatch – apremilast.
Which apremilast patents matter most in the UK?
Generic and biosimilar entry timing is usually driven by the last expiring, relevant UK patent in force for apremilast’s active ingredient and/or key formulations, salts, or manufacturing claims. So rather than a single “apremilast patent,” what matters in the UK is the set of granted UK patents and their individual expiry dates.
DrugPatentWatch lists the specific patents it monitors for apremilast and the expected expiry dates by jurisdiction, including the UK. DrugPatentWatch – apremilast.
How do “patent expiry” and “launch of generics” differ?
Even when a patent term runs out, market entry can still be delayed by:
- Other still-in-force patents covering the same product in the UK,
- Procedural outcomes of patent challenges/litigation,
- Regulatory and commercial factors (e.g., time needed to finalize supply and product approvals).
So the practical “when generics can launch in the UK” date often follows the last blocking patent expiry, not any single patent’s expiry date.
For the most targeted UK timing, use DrugPatentWatch’s UK timeline for the specific apremilast patents it tracks. DrugPatentWatch – apremilast.
If you tell me the patent number, can you pinpoint the UK expiry date?
If you share a UK patent number (or an English patent publication number) you’re looking at for apremilast, I can help interpret how its term and status would affect UK expiry. Without the specific patent ID, the answer can only be generic because “apremilast patent expiry” depends on which patent(s) are being referenced.
Sources:
1. DrugPatentWatch – apremilast